HDAC inhibitors acetylate histones and nonhistone proteins; valproic acid has been shown to restore cell-cycle inhibitors and inhibit proliferation in bladder-cancer models, and it has been explored clinically in non-muscle-invasive disease [45]. This evidence concerns the gene HDAC9 and urinary bladder cancer.